Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway
Authors:
- Weiping YuWYWeiping Yu
- Bob G. SandersBSBob G. Sanders
- Kimberly KlineKKKimberly Kline
- 1 February 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 329 (1) , 9-16
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expressionInternational Journal of Oncology, 2011
- Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growthCellular Signalling, 2010
- Targeting HER2 signaling pathway for radiosensitization: Alternative strategy for therapeutic resistanceCancer Biology & Therapy, 2009
- Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trendsClinical Therapeutics, 2009
- Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis‐associated colon cancer in miceInternational Journal of Cancer, 2008
- HER2 therapy: Molecular mechanisms of trastuzumab resistanceBreast Cancer Research, 2006
- Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer TherapyCurrent Cancer Drug Targets, 2005
- Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway1997
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996
- Regulation of the mevalonate pathwayNature, 1990